EUVIMEDEUVIMED entdecken
Crossref

A Super-Responder Case with Asthma, Chronic Rhinosinusitis and Nasal Polyposis Successfully Treated with Benralizumab

Eduardo Enrique Piñeyro-Beltrán

Revista Alergia México · 30.12.2026 · 73 (4)

DOI: 10.29262/ram.v73i4.32 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Alergia México, online erschienen am 30.12.2026. Verfasst von Eduardo Enrique Piñeyro-Beltrán.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Benralizumab is a humanized, afucosylated anti-eosinophil monoclonal antibody that binds with high affinity and specificity to the alpha subunit of the human interleukin 5 receptor (IL-5Rα). Benralizumab is primarily indicated as an add-on maintenance treatment of adult patients with severe eosinophilic asthma. This monoclonal antibody is increasingly recognized with a therapeutic effect in other entities in which activated eosinophils and basophils have a pivotal role in disease course. CASE REPORT: We herein report a case with nasal polyposis and asthma who was treated with benralizumab with an excellent response, characterized by absence of asthma crisis or rhinosinusitis, without the need of oral steroids, and with a low dose of inhaled medications. CONCLUSION: In conclusion, this case suggests that benralizumab may be considered earlier as a remission induction therapy in patients with asthma and other allergic comorbidities.

Zitieren

APA

Piñeyro-Beltrán, E. E. (2026). A Super-Responder Case with Asthma, Chronic Rhinosinusitis and Nasal Polyposis Successfully Treated with Benralizumab. Revista Alergia México, 73(4). https://doi.org/10.29262/ram.v73i4.32

Vancouver

Piñeyro-Beltrán EE. A Super-Responder Case with Asthma, Chronic Rhinosinusitis and Nasal Polyposis Successfully Treated with Benralizumab. Revista Alergia México. 2026;73(4). doi:10.29262/ram.v73i4.32

BibTeX
@article{PieyroBeltrn2026,
  author = {Piñeyro-Beltrán, Eduardo Enrique},
  title = {A Super-Responder Case with Asthma, Chronic Rhinosinusitis and Nasal Polyposis Successfully Treated with Benralizumab},
  journal = {Revista Alergia México},
  year = {2026},
  volume = {73},
  number = {4},
  doi = {10.29262/ram.v73i4.32}
}
Kostenlos starten →